Michael Doherty

2017

In 2017, Michael Doherty earned a total compensation of $3.4M as Head of Product Development at Foundation Medicine.

Compensation breakdown

Non-Equity Incentive Plan$165,585
Salary$372,692
Stock Awards$2,693,939
Other$183,433
Total$3,415,649

Doherty received $2.7M in stock awards, accounting for 79% of the total pay in 2017.

Doherty also received $165.6K in non-equity incentive plan, $372.7K in salary and $183.4K in other compensation.

Rankings

In 2017, Michael Doherty's compensation ranked 3,098th out of 14,666 executives tracked by ExecPay. In other words, Doherty earned more than 78.9% of executives.

ClassificationRankingPercentile
All
3,098
out of 14,666
79th
Division
Services
587
out of 2,428
76th
Major group
Health Services
41
out of 224
82nd
Industry group
Medical And Dental Laboratories
11
out of 64
83rd
Industry
Medical Laboratories
11
out of 64
83rd
Source: SEC filing on April 27, 2018.

Doherty's colleagues

We found three more compensation records of executives who worked with Michael Doherty at Foundation Medicine in 2017.

2017

Troy Cox

Foundation Medicine

Chief Executive Officer

2017

Michael Pellini

Foundation Medicine

Chief Executive Officer

2017

Steven Kafka

Foundation Medicine

Chief Operating Officer

You may also like